Recognition that LEOPARD syndrome mutations, despite their reduced src homology 2 (SH2) phosphatase activity, have gain-of-function developmental defects provided the first satisfying rationale for how PTPN11 mutations with opposite effects on phosphatase activity might produce analogous phenotypes. The gene discussed is PTPN11; the disease is Noonan syndrome with multiple lentigines.